A phase I study of cancer vaccine with CHP-MAGE-A4 in patients with advanced cancers expressing MAGE-A4 antigen

Trial Profile

A phase I study of cancer vaccine with CHP-MAGE-A4 in patients with advanced cancers expressing MAGE-A4 antigen

Completed
Phase of Trial: Phase I

Latest Information Update: 13 May 2016

At a glance

  • Drugs CHP-MAGE-A4 (Primary)
  • Indications Colon cancer; Gastric cancer; Non-small cell lung cancer; Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Nov 2015 Linked profile to RDI: 43713
    • 15 Aug 2012 Planned end date (Dec 2012) added as reported by University Hospital Medical Information Network - Japan.
    • 15 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top